Degradable biopolymer electrostatic spinning fiber patch for abdominal wall defect repair as well as preparation method and application of degradable biopolymer electrostatic spinning fiber patch
Through the bilayer structure of degradable biopolymer electrospinning fiber patch, the problems of inflammation and adhesion of abdominal wall defect repair materials after implantation are solved, excellent mechanical properties and biocompatibility are achieved, and abdominal wall damage is promoted. Quick fix.
Patent Information
- Application Number
- CN202411176977.9
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-08-26
- Publication Date
- 2024-11-29
AI Technical Summary
The existing abdominal wall defect repair materials are prone to inflammatory reactions and intra-abdominal adhesions after implantation, and their mechanical properties are insufficient, making it difficult to effectively accelerate the repair of abdominal wall damage.
Degradable biopolymer electrospinning fiber patches adopting a bilayer structure. The inner layer is a polymer polymer fiber layer arranged in a one-way orderly manner, and the outer layer is a polymer polymer fiber layer arranged in an irregular manner. The surface is deposition and growth Factor nanoparticles, containing biologically active substances to simulate extracellular matrix, provide physical and biochemical signals that promote cell migration and repair.
This material has excellent mechanical properties, can withstand the stress of daily activities, reduce inflammatory response, promote rapid repair of abdominal wall defects, avoid intraabdominal adhesions, and delayed release of biological active factors extends the action time, and improves repair efficiency.
Smart Images

Figure CN119034002A_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of biomaterials, and in particular to a degradable biopolymer electrostatically spun fiber patch for abdominal wall defect repair, a preparation method and an application thereof. Background Art
[0002] Abdominal wall defects are caused by congenital gastroschisis, trauma and abdominal surgery, which can lead to hernia formation, intestinal incarceration and necrosis, and even death in severe cases. With the increasing number of patients with abdominal wall defects, abdominal wall defects have become an important medical problem in the field of trauma repair. At present, patches are mainly used in clinical practice to repair abdominal wall defects. The patches currently used in clinical practice have problems such as insufficient mechanical strength, inducing local inflammation and causing intra-abdominal adhesions. The development of surgical patches with excellent mechanical properties, no intra-abdominal adhesions, and the ability to accelerate the repair of abdominal wall injuries has important clinical significance and socioeconomic value.
[0003] To solve the above problems, it is necessary to design appropriate repair materials based on the mechanism of intra-abdominal adhesion and the mechanism of abdominal wall repair. Postoperative intra-abdominal adhesion is mainly caused by exogenous materials (such as Surgipro TM ; ) The strong inflammatory stimulation caused by implantation leads to the interweaving of fibrin bands between the patch at the injured site and the adjacent tissues or organs, which in turn forms adhesions. Therefore, reducing the inflammatory response caused by implanted materials is the key to reducing intra-abdominal adhesions; abdominal wall defects mainly involve damage to muscles and peritoneum. The peritoneum is composed of mesothelial cells. During the repair process, mesothelial cells are activated by bioactive molecules and proliferate to form peritoneum. Muscle tissue damage and repair are carried out through the activation of satellite cells. In this process, the extracellular matrix and a variety of bioactive molecules work together to regulate the proliferation, migration, and differentiation of a variety of cells. Therefore, it is necessary to develop a patch with excellent mechanical strength, no inflammatory response, and containing bioactive molecules to promote tissue regeneration and repair.
[0004] Electrospun fibers have a structure similar to that of the extracellular matrix and excellent mechanical properties. They are not prone to inflammatory reactions and can withstand the stress generated by daily activities at the site of injury, meeting the requirements of surgical patches at abdominal wall defects. However, electrospun fiber scaffold materials with a single structure usually cannot guide the repair of abdominal wall defects. By constructing a specific topological structure and introducing bioactive substances on the fiber surface, physical and biochemical signals can be provided for cell migration, thereby accelerating the repair of injuries. At the same time, adding pro-repair growth factors to the active factors and regulating their sustained release, which can act on the injury site for a long time, can effectively improve the efficiency and effect of injury repair, which is a hot topic of current research.
[0005] Currently, polypropylene (PP) patches and acellular extracellular matrix (AECM), such as porcine small intestinal submucosa and dermal matrix, are used clinically. Surgipro TM ) Although it has excellent mechanical properties, it can cause strong inflammatory reactions and form intra-abdominal adhesions. TM ; SurgiMend TM ) retains the components of the extracellular matrix, which helps in rapid integration of the graft and wound healing, but its application is greatly limited due to the rapid degradation of the material in the body, resulting in loss of mechanical properties.
[0006] In view of this, the present invention is proposed. Summary of the invention
[0007] The purpose of the present invention is to provide a degradable polymer electrospun fiber patch which has excellent mechanical properties, does not cause intra-abdominal adhesion, and can accelerate the repair of abdominal wall injuries, as well as a preparation method and application.
[0008] To achieve one of the above purposes, the present invention provides the following technical solutions:
[0009] A biodegradable biopolymer electrospun fiber patch for abdominal wall defect repair, the fiber patch comprising an inner polymer fiber layer and an outer polymer fiber layer, and growth factor nanoparticles are deposited on the surface of the inner polymer fiber layer. The thickness of the inner polymer fiber layer and the outer polymer fiber layer is 50 to 800 μm, preferably 100 to 500 μm. The particle size of the growth factor nanoparticles is 30 to 200 nm, preferably 50 to 150 nm.
[0010] Preferably, the inner polymer fiber layer is a fiber layer formed by a unidirectional orderly arranged high molecular polymer or a fiber layer formed by a mixture of a unidirectional orderly arranged high molecular polymer and a natural polymer;
[0011] The outer polymer fiber layer is a fiber layer formed by randomly arranged high molecular polymers.
[0012] Preferably, the high molecular weight polymer is a degradable aliphatic polyester.
[0013] Preferably, the degradable aliphatic polyester is at least one of polylactic acid, polycaprolactone, polylactic acid-glycolic acid copolymer, and polylactic acid-glycolic acid-caprolactone copolymer.
[0014] Preferably, the growth factor nanoparticles include a core layer and a shell layer, the core layer is a growth factor, and the shell layer is a bioactive substance.
[0015] Preferably, the bioactive substance is at least one of laminin, fibronectin, collagen, and albumin;
[0016] The growth factor is at least one of vascular endothelial growth factor, fibroblast growth factor, epidermal growth factor, hepatocyte growth factor and platelet-derived growth factor.
[0017] To achieve the second of the above objectives, the present invention provides the following technical solutions:
[0018] A method for preparing a degradable biopolymer electrospun fiber patch for abdominal wall defect repair comprises the following steps:
[0019] Step (1): electrospinning a mixed solution A of a high molecular weight polymer and a natural polymer and a polymer solution B to prepare a double-layer polymer fiber layer;
[0020] Step (2) The growth factor solution C and the bioactive substance solution D are coaxially electrostatically sprayed onto the surface of the inner polymer fiber layer, so that the growth factor nanoparticles are electrostatically deposited on the inner polymer fiber layer.
[0021] Preferably, in step (1):
[0022] The solvent in the natural polymer solution A is selected from at least one of hexafluoroisopropanol, trifluoroethanol, chloroform, methanol, dichloromethane, and N,N'-dimethylformamide;
[0023] The mass percentage concentration of the natural polymer solution A is 5 to 25%, preferably 8 to 15%;
[0024] The mass ratio of the natural polymer to the high molecular weight polymer in the natural polymer solution A is 1:9 to 6:4; preferably 3:7 to 5:5;
[0025] The solvent in the polymer solution B is selected from at least one of hexafluoroisopropanol, trifluoroethanol, chloroform, methanol, dichloromethane, and N,N'-dimethylformamide;
[0026] The mass percentage concentration of the polymer solution B is 5 to 25%, preferably 8 to 15%.
[0027] The electrospinning specifically includes: uniaxial electrospinning of natural polymer solution A and polymer solution B, with a roller or a U-shaped groove as a receiver, a spinning solution flow rate of 0.1 to 3 mL / h, a voltage of 10 to 20 kV, and a receiving distance of 10 to 20 cm; when a roller is used as a receiver, firstly using the natural polymer solution A with a high-speed rotating roller as a receiver for spinning for 2 to 10 hours, and then using the polymer solution B with the roller speed reduced for spinning for 2 to 10 hours; or, when a U-shaped groove is used as a receiver, firstly using the natural polymer solution A with the U-shaped groove as a receiver for spinning for 2 to 10 hours, and then peeling the collected fiber membrane from the U-shaped groove, removing the U-shaped groove, placing the obtained fiber membrane on tin foil as a receiver, and using the polymer solution B for spinning for 2 to 10 hours.
[0028] Preferably, in step (2):
[0029] The solvent of the growth factor solution C is selected from at least one of phosphate buffered saline, water, ethanol, polyvinyl alcohol, polyacrylamide, and polyacrylic acid;
[0030] The concentration of growth factor solution C is 0.1 μg / mL to 5 mg / mL; preferably 1 μg / mL to 1 mg / mL;
[0031] The solvent in the bioactive substance solution D is selected from at least one of acetic acid, water, ethanol, methanol, and physiological saline;
[0032] The concentration of the bioactive substance solution D is 1 to 50 mg / mL; preferably 10 to 30 mg / mL;
[0033] The coaxial electrostatic spraying specifically comprises: injecting the bioactive substance solution D into the shell layer syringe, injecting the growth factor solution C into the core layer syringe, the inner polymer fiber layer obtained in step (1) is used as a receiver, the flow rate of the shell layer electrospraying solution is 0.5-3 mL / h, the flow rate of the core layer electrospraying solution is 0.2-1 mL / h, the voltage is 10-20 kV, the receiving distance is 10-20 cm, and the electrostatic spraying time is 1-60 min.
[0034] To achieve the third objective above, the present invention provides the following technical solutions:
[0035] A biodegradable biopolymer electrospun fiber patch for abdominal wall defect repair as described above, or a biodegradable biopolymer electrospun fiber patch for abdominal wall defect repair obtained by the preparation method as described above, and its application in abdominal wall defect repair materials
[0036] Compared with the prior art, the biodegradable biopolymer electrospun fiber patch for abdominal wall defect repair proposed by the present invention has excellent mechanical properties and can withstand the stress generated in the abdominal wall in daily life after being implanted in the abdominal wall defect.
[0037] The inner layer of the fiber patch is a unidirectional orderly arranged structure, which provides physical signals for the recruitment and migration of cells, promotes cell migration to the injured site, and accelerates the repair of abdominal wall defects.
[0038] The fiber patch is loaded with bioactive factor particles, including a variety of bioactive substances that make up the extracellular matrix and growth factors required for abdominal wall repair, so that the patch simulates the composition and structure of the extracellular matrix under natural repair conditions as much as possible, and thus has good biocompatibility, and can avoid the occurrence of organ adhesion induced by strong inflammation caused by material implantation; the bioactive factors can also regulate the migration, proliferation, and differentiation of related cells, and accelerate the repair of abdominal wall defects.
[0039] The growth factors encapsulated in the bioactive factor microparticles can be slowly released as the bioactive substances degrade, avoiding the rapid inactivation of the growth factors in the body, prolonging the action time of the growth factors in the damaged area, improving the efficiency of the growth factors, and reducing the cost of treatment.
[0040] In order to make the above-mentioned objects, features and advantages of the present invention more obvious and easy to understand, preferred embodiments are given below and described in detail with reference to the accompanying drawings. BRIEF DESCRIPTION OF THE DRAWINGS
[0041] In order to more clearly illustrate the technical solutions of the embodiments of the present invention, the drawings required for use in the embodiments are briefly introduced below. It should be understood that the following drawings only show certain embodiments of the present invention and therefore should not be regarded as limiting the scope. For ordinary technicians in this field, other related drawings can be obtained based on these drawings without creative work.
[0042] Figure 1 (a) is the water contact angle image of the outer polymer fiber layer in the fiber patch prepared in Example 1 of the present invention.
[0043] Figure 1 (b) is the water contact angle image of the outer polymer fiber layer in the fiber patch prepared in Example 1 of the present invention.
[0044] Figure 2 (a) is the stress-strain curve of the fiber patch prepared in Example 1 of the present invention in the vertical unidirectional ordered direction.
[0045] Figure 2(b) is the stress-strain curve in the unidirectional ordered direction of the fiber patch prepared in Example 1 of the present invention.
[0046] Figure 3 (a) is a scanning electron microscope image of the inner polymer fiber layer in the fiber patch prepared in Example 1 of the present invention.
[0047] Figure 3 (b) is a distribution diagram of the nanofiber diameters of the inner polymer fiber layer in the fiber patch prepared in Example 1 of the present invention.
[0048] Figure 3 (c) is a scanning electron microscope image of the outer polymer fiber layer in the fiber patch prepared in Example 1 of the present invention.
[0049] Figure 3 (d) is a distribution diagram of nanofiber diameters in the outer polymer fiber layer of the fiber patch prepared in Example 1 of the present invention.
[0050] Figure 4 (a) is the angiogenesis fluorescence image of human umbilical vein endothelial cells under the action of different materials in the present invention.
[0051] Figure 4 (b) is the total length of the blood vessels of human umbilical vein endothelial cells in the present invention under the action of different materials.
[0052] Figure 4 (c) is the percentage of blood vessel area of human umbilical vein endothelial cells under the action of different materials in the present invention.
[0053] Figure 4 (d) is the total number of vascular network nodes of human umbilical vein endothelial cells under the action of different materials in the present invention. DETAILED DESCRIPTION
[0054] The technical solutions in the embodiments of the present invention will be clearly and completely described below in conjunction with the drawings in the embodiments of the present invention. Obviously, the described embodiments are only a part of the embodiments of the present invention, rather than all the embodiments. The components of the embodiments of the present invention generally described and shown in the drawings here can be arranged and designed in various different configurations. Therefore, the following detailed description of the embodiments of the present invention provided in the drawings is not intended to limit the scope of the claimed invention, but merely represents the selected embodiments of the present invention. Based on the embodiments of the present invention, all other embodiments obtained by those skilled in the art without making creative work belong to the scope of protection of the present invention.
[0055] Example 1
[0056] Step (1) adding polycaprolactone to a mixed solution of dichloromethane and N,N-dimethylformamide (the volume ratio of dichloromethane to N,N-dimethylformamide is 4:1), stirring magnetically at room temperature for 24 hours, adding gelatin (the mass ratio of gelatin to polycaprolactone is 3:7), stirring magnetically at room temperature for 48 hours, adding 0.2% acetic acid, and obtaining a mixed solution A of natural polymer and high molecular polymer with a mass concentration of 10%; adding polycaprolactone to a mixed solution of dichloromethane and N,N-dimethylformamide (the volume ratio of dichloromethane to N,N-dimethylformamide is 4:1), stirring magnetically at room temperature for 24 hours, adding gelatin (the mass ratio of gelatin to polycaprolactone is 3:7), stirring magnetically at room temperature for 48 hours, and adding 0.2% acetic acid to obtain a mixed solution A of natural polymer and high molecular polymer with a mass concentration of 10%; , magnetic stirring at room temperature for 24 hours, to obtain a polymer solution B with a mass concentration of 10%, and uniaxial electrospinning was performed with solution A, the flow rate of solution A was 1.5 mL / h, the voltage was 16 kV, the receiving distance was 15 cm, and a high-speed rotating roller was used as a receiver. The spinning was performed for 6.5 hours to obtain unidirectional ordered fibers, and then uniaxial electrospinning was performed with solution B, while the roller speed was reduced, and the randomly arranged fibers were continuously collected for 6.5 hours to obtain a double-layer structure polymer fiber membrane; the polymer fiber membrane was placed in a fume hood at room temperature for 3 days to allow the residual solvent to fully evaporate;
[0057] Step (2) dissolving vascular endothelial cell growth factor in PBS and mixing well to obtain a growth factor solution C with a concentration of 100 μg / mL; dissolving collagen in an acetic acid aqueous solution with a volume fraction of 70%, mixing well to obtain a bioactive substance solution D with a concentration of 20 mg / mL; replacing the electrospray liquid with the growth factor solution C and the bioactive substance solution D, replacing the uniaxial spinning needle with a coaxial needle, injecting the growth factor solution C into the core layer syringe, and injecting the bioactive substance solution D into the shell layer syringe; the inner layer of the polymer fiber membrane obtained in step (1) is used as a receiver, and coaxial electrostatic spraying is performed to deposit bioactive substance particles on the surface of the inner layer of the fiber membrane, the flow rate of the growth factor solution C is 0.5 mL / h, the flow rate of the bioactive substance solution D is 1.5 mL / h, the voltage is 20 kV, and the electrostatic spraying is performed for 10 minutes to deposit bioactive substance particles on the inner surface of the polymer fiber membrane, thereby obtaining a surgical patch material capable of sustained-release growth factors and preventing intra-abdominal adhesion.
[0058] Example 2
[0059] Step (1) adding a polylactic acid-co-glycolic acid (PLGA) solution to a mixed solution of dichloromethane and N,N-dimethylformamide (the volume ratio of dichloromethane to N,N-dimethylformamide is 4:1), magnetically stirring at room temperature for 24 hours, adding chitosan (the mass ratio of chitosan to PLGA is 4:6), magnetically stirring at room temperature for 48 hours, adding 0.2% acetic acid, and obtaining a mixed solution A of natural polymer and high molecular polymer with a mass concentration of 10%; adding polycaprolactone to a mixed solution of dichloromethane and N,N-dimethylformamide (the volume ratio of dichloromethane to N,N-dimethylformamide is 4:1), magnetically stirring at room temperature for 24 hours, adding chitosan (the mass ratio of chitosan to PLGA is 4:6), magnetically stirring at room temperature for 48 hours, and adding 0.2% acetic acid to obtain a mixed solution A of natural polymer and high molecular polymer with a mass concentration of 10%; The volume ratio is 4:1), and magnetic stirring is performed at room temperature for 24 hours to obtain a polymer solution B with a mass concentration of 10%, and solution A is used for uniaxial electrospinning, the flow rate of solution A is 1.5 mL / h, the voltage is 16 kV, the receiving distance is 15 cm, and a high-speed rotating roller is used as a receiver. The spinning is performed for 6.5 hours to obtain unidirectional orderly arranged fibers, and then solution B is used for uniaxial electrospinning, while the roller speed is reduced, and the randomly arranged fibers are continuously collected for 6.5 hours to obtain a double-layer structure polymer fiber membrane; the polymer fiber membrane is placed in a fume hood at room temperature for 3 days to allow the residual solvent to fully evaporate;
[0060] Step (2) dissolving epidermal cell growth factor in PBS and mixing well to obtain a growth factor solution C with a concentration of 100 μg / mL; dissolving collagen in an acetic acid aqueous solution with a volume fraction of 70%, mixing well to obtain a bioactive substance solution D with a concentration of 20 mg / mL; replacing the electrospray liquid with growth factor solution C and bioactive substance solution D, replacing the uniaxial spinning needle with a coaxial needle, injecting the growth factor solution C into the core layer syringe, and injecting the bioactive substance solution D into the shell layer syringe; the inner layer of the polymer fiber membrane obtained in step (1) is used as a receiver, and coaxial electrostatic spraying is performed to deposit bioactive substance particles on the surface of the inner layer of the fiber membrane, the flow rate of the growth factor solution C is 0.5 mL / h, the flow rate of the bioactive substance solution D is 1.5 mL / h, the voltage is 20 kV, and the electrostatic spraying is performed for 10 minutes to deposit bioactive substance particles on the inner surface of the polymer fiber membrane, thereby obtaining a surgical patch material capable of sustained-release growth factors and preventing intra-abdominal adhesion.
[0061] Example 3
[0062] Step (1) adding a polylactic acid-co-glycolic acid (PLGA) solution to a mixed solution of dichloromethane and N,N-dimethylformamide (the volume ratio of dichloromethane to N,N-dimethylformamide is 4:1), magnetically stirring at room temperature for 24 hours, adding gelatin (the mass ratio of gelatin to PLGA is 4:6), magnetically stirring at room temperature for 48 hours, adding 0.2% acetic acid, and obtaining a mixed solution A of natural polymer and high molecular polymer with a mass concentration of 10%; adding PLGA to a mixed solution of dichloromethane and N,N-dimethylformamide (the volume ratio of dichloromethane to N,N-dimethylformamide is 4:1), stirring at room temperature for 24 hours, adding gelatin (the mass ratio of gelatin to PLGA is 4:6), magnetically stirring at room temperature for 48 hours, and adding 0.2% acetic acid to obtain a mixed solution A of natural polymer and high molecular polymer with a mass concentration of 10%; The ratio is 4:1), and magnetic stirring is performed at room temperature for 24 hours to obtain a polymer solution B with a mass concentration of 10%, and the solution A is used for uniaxial electrospinning, the flow rate of the solution A is 1.5 mL / h, the voltage is 16 kV, the receiving distance is 15 cm, and a high-speed rotating roller is used as a receiver. The spinning is performed for 6.5 hours to obtain unidirectional orderly arranged fibers, and then the solution B is used for uniaxial electrospinning, while the roller speed is reduced, and the randomly arranged fibers are continuously collected for 6.5 hours to obtain a double-layer structure polymer fiber membrane; the polymer fiber membrane is placed in a fume hood at room temperature for 3 days to allow the residual solvent to fully evaporate;
[0063] Step (2) dissolving vascular endothelial growth factor and epidermal growth factor in PBS, and mixing them thoroughly to obtain a growth factor solution C with a growth factor concentration of 100 μg / mL; dissolving collagen in an acetic acid aqueous solution with a volume fraction of 70%, and mixing them thoroughly to obtain a bioactive substance solution D with a concentration of 20 mg / mL; replacing the electrospray liquid with the growth factor solution C and the bioactive substance solution D, replacing the uniaxial spinning needle with a coaxial needle, injecting the growth factor solution C into the core layer syringe, and injecting the bioactive substance solution D into the shell layer syringe; the inner layer of the polymer fiber membrane obtained in step (1) is used as a receiver, and coaxial electrostatic spraying is performed to deposit bioactive substance particles on the surface of the inner layer of the fiber membrane, the flow rate of the growth factor solution C is 0.5 mL / h, the flow rate of the bioactive substance solution D is 1.5 mL / h, the voltage is 20 kV, and the electrostatic spraying is performed for 10 minutes to deposit bioactive substance particles on the inner surface of the polymer fiber membrane, thereby obtaining a surgical patch material capable of sustained-release growth factors and preventing intra-abdominal adhesion.
[0064] Example 4
[0065] Step (1) preparing a polycaprolactone solution with trifluoroethanol, magnetically stirring at room temperature for 24 hours, adding gelatin (the mass ratio of gelatin to PLGA is 4:6), magnetically stirring at room temperature for 48 hours, and adding 0.2% acetic acid to obtain a natural polymer and high molecular polymer mixed solution A with a mass concentration of 10%; preparing a polycaprolactone solution with trifluoroethanol, magnetically stirring at room temperature for 24 hours, obtaining a high molecular polymer solution B with a mass concentration of 10%, performing uniaxial electrospinning with solution A, the flow rate of solution A is 1.5 mL / h, the voltage is 16 kV, the receiving distance is 15 cm, a high-speed rotating roller is used as a receiver, spinning for 6.5 hours, obtaining unidirectional orderly arranged fibers, then performing uniaxial electrospinning with solution B, while reducing the roller speed, continuing to collect randomly arranged fibers, collecting for 6.5 hours, and obtaining a double-layer polymer fiber membrane; placing the polymer fiber membrane in a fume hood at room temperature for 3 days to allow the residual solvent to fully evaporate;
[0066] Step (2) dissolving epidermal cell growth factor in PBS and mixing well to obtain a growth factor solution C with a concentration of 100 μg / mL; dissolving collagen in an acetic acid aqueous solution with a volume fraction of 70%, mixing well to obtain a bioactive substance solution D with a concentration of 20 mg / mL; replacing the electrospray liquid with growth factor solution C and bioactive substance solution D, replacing the uniaxial spinning needle with a coaxial needle, injecting the growth factor solution C into the core layer syringe, and injecting the bioactive substance solution D into the shell layer syringe; the inner layer of the polymer fiber membrane obtained in step (1) is used as a receiver, and coaxial electrostatic spraying is performed to deposit bioactive substance particles on the surface of the inner layer of the fiber membrane, the flow rate of the growth factor solution C is 0.5 mL / h, the flow rate of the bioactive substance solution D is 1.5 mL / h, the voltage is 20 kV, and the electrostatic spraying is performed for 10 minutes to deposit bioactive substance particles on the inner surface of the polymer fiber membrane, thereby obtaining a surgical patch material capable of sustained-release growth factors and preventing intra-abdominal adhesion.
[0067] Comparative Example 1
[0068] Porcine small intestinal submucosa patch (Surgisis Saiding Q, Chen Y, Wang J, et al. Abdominal wall hernia repair: From prosthetic meshes to smart materials [J]. Materials Today Bio, 2023: 100691.).
[0069] The porcine small intestinal submucosal patch prepared in Comparative Example 1 has stronger biocompatibility and a lighter inflammatory response after implantation in the body, but has lower mechanical strength and a faster degradation rate in the body, thus easily leading to recurrence of hernia.
[0070] Figure 2 The stress-strain curve of the fiber patch prepared in Example 1 is shown. By comparing the stress-strain curve of Example 1 with the stress-strain curve of Comparative Example 1, the polymer fiber with growth factor particles deposited on the inner surface in Example 1 has excellent mechanical properties. In addition, since the polyester material degrades slowly in the body, the mechanical property degradation of the patch caused by rapid degradation of the material can be prevented. Compared with the pig small intestinal submucosal patch, the probability of hernia recurrence is greatly reduced.
[0071] Comparative Example 2
[0072] Single strand mesh polypropylene patch ( See CW, Kim T, Zhu D. Hernia mesh and hernia repair: a review[J]. Engineered Regeneration, 2020, 1: 19-33.).
[0073] The single-strand polypropylene patch prepared in Comparative Example 2 has excellent mechanical properties, stable chemical properties, and low price, and is widely used in clinical treatment. However, it can cause a strong inflammatory reaction in the body, leading to the occurrence of intra-abdominal adhesions, and even intestinal obstruction or intestinal fistula in severe cases. Therefore, the implantation position cannot contact the intra-abdominal organs, which limits its application. At the same time, the surface of the polypropylene patch is rough, and implantation in the body can cause chronic pain and poor comfort.
[0074] Figure 1 This is the water contact angle image of the polymer fiber with growth factor particles deposited on the inner surface obtained in Example 1, which illustrates that the inner layer of the polymer fiber with growth factor particles deposited on the inner surface in Example 1 is hydrophilic, and unlike the hydrophobic polypropylene patch, it is not easy to cause inflammatory response, and will not cause intra-abdominal adhesion when in contact with the intra-abdominal organs, and is conducive to the growth of new tissue. Figure 3 This is a scanning electron microscope image of the polymer fiber with growth factor particles deposited on the inner surface obtained in Example 1, which illustrates that the polymer fiber with growth factor particles deposited on the inner surface in Example 1 has high porosity, high specific surface volume, and a structure similar to the extracellular matrix. Compared with the rough-surfaced polypropylene patch, it does not cause chronic pain after implantation in the body and has higher comfort.
[0075] Comparative Example 3
[0076] Zhou et al. (Zhou X, Said Q, Wang X, et al. Regulated Exogenous / Endogenous Inflammation via "Inner-Outer" Medicated Electrospun Fibers for Promoting Tissue Reconstruction [J]. Advanced healthcare materials, 2022, 11 (10): 2102534.) prepared a core-shell nanofiber with a shell layer of polylactic acid and a core layer of nanoparticles encapsulating puerarin by microsol spinning technology, and modified the fiber membrane surface with arginine-glycine-aspartic acid tripeptide (RGD). The fiber membrane inhibits exogenous inflammation through RGD surface modification and puerarin loaded in the core to inhibit endogenous inflammation for a long time, without introducing bioactive substances to accelerate wound repair. The polymer fiber with growth factor particles deposited on the inner surface obtained in Example 1 can release growth factors after implantation in the body, regulate the proliferation, migration and differentiation of various cells at the injured site, thereby accelerating the healing of postoperative wounds. Compared with the above-mentioned studies without the introduction of bioactive substances, it can promote wound repair and improve the patient's prognosis.
[0077] In addition, the in vitro angiogenesis experiment was used to evaluate the effect of the fiber membrane patch on promoting angiogenesis. Human umbilical vein endothelial cells were cultured for 4 hours in ordinary culture medium, fiber membrane patch extract, fiber membrane patch extract loaded with collagen particles, fiber membrane patch extract loaded with collagen particles containing epidermal growth factor (EGF), fiber membrane patch extract loaded with collagen particles containing vascular endothelial growth factor (VEGF), and fiber membrane patch extract loaded with collagen particles containing EGF and VEGF, and then HUVECs were stained with calcein and observed under a microscope. Figure 4 As shown in (a), the fiber membrane patch loaded with growth factors has a significant promoting effect on the formation of vascular network. Angiotool software was used to quantify the total length of blood vessels, percentage of blood vessel area, and total number of vascular network nodes in each group. Figure 4 As shown in (bd), the results further illustrate that the present invention promotes the formation of vascular networks, and the formed vascular networks have longer total blood vessel lengths, a larger percentage of blood vessel area, and a greater total number of vascular network nodes.
[0078] The above description is only a preferred embodiment of the present invention and is not intended to limit the present invention. For those skilled in the art, the present invention may have various modifications and variations. Any modifications, equivalent substitutions, improvements, etc. made within the spirit and principles of the present invention should be included in the protection scope of the present invention. It should be noted that similar numbers and letters represent similar items in the following drawings. Therefore, once an item is defined in one drawing, it does not need to be further defined and explained in the subsequent drawings.
Claims
1. A biodegradable biopolymer electrospun fiber patch for abdominal wall defect repair, characterized in that: The fiber patch comprises an inner polymer fiber layer and an outer polymer fiber layer, and growth factor nanoparticles are deposited on the surface of the inner polymer fiber layer.
2. The degradable biopolymer electrospun fiber patch for abdominal wall defect repair according to claim 1, characterized in that: The inner polymer fiber layer is a fiber layer formed by a unidirectional orderly arranged high molecular polymer or a fiber layer formed by a mixture of a unidirectional orderly arranged high molecular polymer and a natural polymer; The outer polymer fiber layer is a fiber layer formed by randomly arranged high molecular polymers.
3. The degradable biopolymer electrospun fiber patch for abdominal wall defect repair according to claim 2, characterized in that: The high molecular polymer is a degradable aliphatic polyester.
4. The degradable biopolymer electrospun fiber patch for abdominal wall defect repair according to claim 3, characterized in that: The degradable aliphatic polyester is at least one of polylactic acid, polycaprolactone, polylactic acid-glycolic acid copolymer, and polylactic acid-glycolic acid-caprolactone copolymer.
5. The degradable biopolymer electrospun fiber patch for abdominal wall defect repair according to claim 1, characterized in that: The growth factor nanoparticles include a core layer and a shell layer, wherein the core layer is a growth factor and the shell layer is a bioactive substance.
6. The degradable biopolymer electrospun fiber patch for abdominal wall defect repair according to claim 5, characterized in that: The bioactive substance is at least one of laminin, fibronectin, collagen, and albumin; The growth factor is at least one of vascular endothelial growth factor, fibroblast growth factor, epidermal growth factor, hepatocyte growth factor and platelet-derived growth factor.
7. A method for preparing a degradable biopolymer electrospun fiber patch for abdominal wall defect repair, characterized in that: The steps include: Step (1): electrospinning a mixed solution A of a high molecular weight polymer and a natural polymer and a polymer solution B to prepare a double-layer polymer fiber layer; Step (2) The growth factor solution C and the bioactive substance solution D are coaxially electrostatically sprayed onto the surface of the inner polymer fiber layer, so that the growth factor nanoparticles are electrostatically deposited on the inner polymer fiber layer.
8. The method for preparing a degradable biopolymer electrospun fiber patch for abdominal wall defect repair according to claim 7, characterized in that: In the step (1): The solvent in the natural polymer solution A is selected from at least one of hexafluoroisopropanol, trifluoroethanol, chloroform, methanol, dichloromethane, and N,N'-dimethylformamide; The mass percentage concentration of the natural polymer solution A is 5 to 25%; The mass ratio of the natural polymer to the high molecular weight polymer in the natural polymer solution A is 1:9 to 6:4; The solvent in the polymer solution B is selected from at least one of hexafluoroisopropanol, trifluoroethanol, chloroform, methanol, dichloromethane, and N,N'-dimethylformamide; The mass percentage concentration of the polymer solution B is 5 to 25%; The electrospinning specifically includes: uniaxial electrospinning of natural polymer solution A and polymer solution B, with a roller or a U-shaped groove as a receiver, a spinning solution flow rate of 0.1 to 3 mL / h, a voltage of 10 to 20 kV, and a receiving distance of 10 to 20 cm; when a roller is used as a receiver, firstly using the natural polymer solution A with a high-speed rotating roller as a receiver for spinning for 2 to 10 hours, and then using the polymer solution B with the roller speed reduced for spinning for 2 to 10 hours; or, when a U-shaped groove is used as a receiver, firstly using the natural polymer solution A with the U-shaped groove as a receiver for spinning for 2 to 10 hours, and then peeling the collected fiber membrane from the U-shaped groove, removing the U-shaped groove, placing the obtained fiber membrane on tin foil as a receiver, and using the polymer solution B for spinning for 2 to 10 hours.
9. The method for preparing a degradable biopolymer electrospun fiber patch for abdominal wall defect repair according to claim 7, characterized in that: In step (2): The solvent of the growth factor solution C is selected from at least one of phosphate buffered saline, water, ethanol, polyvinyl alcohol, polyacrylamide, and polyacrylic acid; The concentration of growth factor solution C is 0.1 μg / mL to 5 mg / mL; The solvent in the bioactive substance solution D is selected from at least one of acetic acid, water, ethanol, methanol, and physiological saline; The concentration of the bioactive substance solution D is 1 to 50 mg / mL; The coaxial electrostatic spraying specifically comprises: injecting the bioactive substance solution D into the shell layer syringe, injecting the growth factor solution C into the core layer syringe, the inner polymer fiber layer obtained in step (1) is used as a receiver, the flow rate of the shell layer electrospraying solution is 0.5-3 mL / h, the flow rate of the core layer electrospraying solution is 0.2-1 mL / h, the voltage is 10-20 kV, the receiving distance is 10-20 cm, and the electrostatic spraying time is 1-60 min.
10. Use of a degradable biopolymer electrospun fiber patch for abdominal wall defect repair as described in any one of claims 1 to 6, or a degradable biopolymer electrospun fiber patch for abdominal wall defect repair obtained by the preparation method of claims 7 to 9 in abdominal wall defect repair materials.
Citation Information
Cited By
Degradable aortic dissection repair patch and preparation method thereof
CN120789337A
